New data highlights clinical utility and performance of castle biosciences' dermatologic test portfolio at the 2023 fall clinical dermatology conference®

Friendswood, texas--(business wire)---- $cstl #decisiondxmelanoma--castle will share new data across its dermatologic portfolio of gene expression profile (gep) tests at the 2023 fall clinical dermatology conference®.
CSTL Ratings Summary
CSTL Quant Ranking